40
Participants
Start Date
January 31, 2017
Primary Completion Date
June 30, 2018
Study Completion Date
July 31, 2018
VAL070-A
After randomization (V1 visit), 8 capsules per day of VAL070-A during 12 weeks (from visit V1 to visit V2). They will consume 3 capsules at the beginning of their breakfast, 2 capsules at the beginning of their lunch and 3 capsules at the beginning of their dinner.
VAL070-B
After randomization (V1 visit), 8 capsules per day of VAL070-B during 12 weeks (from visit V1 to visit V2). They will consume 3 capsules at the beginning of their breakfast, 2 capsules at the beginning of their lunch and 3 capsules at the beginning of their dinner.
Placebo
After randomization (V1 visit), 8 capsules per day of placebo during 12 weeks (from visit V1 to visit V2). They will consume 3 capsules at the beginning of their breakfast, 2 capsules at the beginning of their lunch and 3 capsules at the beginning of their dinner.
Biofortis Mérieux NutriSciences Clinical Investigation Center, Saint-Herblain
Biofortis Mérieux NutriSciences
OTHER
Valbiotis
INDUSTRY